Welcome to the November 2020 edition of the Site Engagement newsletter. This newsletter is dedicated to keeping you informed of news and trends as it relates to site engagement within clinical development.
In this edition, read insights and updates from PRA’s Site Engagement Team. We explore the role of Clinical Trial Liaisons and how their work benefits clinical trial design and helps unite client teams that work with PRA. Also covered is an innovative SCD treatment method focused on genetic editing with CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) DNA and Cas (CRISPR-associated) enzymes.
We’ve contributed to the successful approval of eight marketed cardiovascular and cardio-metabolic drugs.
Every day we’re making breakthroughs in how we use data to answer questions, but we’re also making breakthroughs in how our data is empowering our…
Creating Participant-Centric Trials with Remote Participant Monitoring
Improving diversity in the clinical research workforce may improve diversity among clinical trial participants, healthcare access, and equity of care.